Search Results (336)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Drug Design | Concept |
Why?
|
| Open data-driven infrastructure for building biomolecular force fields for predictive biophysics and drug design | Grant |
Why?
|
| Best practices in free energy calculations for drug design. | Academic Article |
Why?
|
| Hemoglobin-based oxygen carriers: From mechanisms of toxicity and clearance to rational drug design. | Academic Article |
Why?
|
| The use of ribosomal crystal structures in antibiotic drug design. | Academic Article |
Why?
|
| Cell biology. Lessons in rational drug design for protein kinases. | Academic Article |
Why?
|
| Nicotinic receptors containing the alpha7 subunit: a model for rational drug design. | Academic Article |
Why?
|
| Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal Cancer. | Academic Article |
Why?
|
| Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy. | Academic Article |
Why?
|
| Application of statistical 'design of experiments' methods in drug discovery. | Academic Article |
Why?
|
| Boehringer Mannheim award lecture 1995. La conference Boehringer Mannheim 1995. De novo design of alpha-helical proteins: basic research to medical applications. | Academic Article |
Why?
|
| Building a Better Insulin - Whom Will It Help? | Academic Article |
Why?
|
| Combinatorial drug discovery: which methods will produce the greatest value? | Academic Article |
Why?
|
| Deconvolution of combinatorial libraries for drug discovery: a model system. | Academic Article |
Why?
|
| Design and synthesis of 3-(3-((9H-carbazol-4-yl)oxy)-2-hydroxypropyl)-2-phenylquinazolin-4(3H)-one derivatives to induce ACE inhibitory activity. | Academic Article |
Why?
|